Home Other Building Blocks 5928-25-6
5928-25-6,MFCD00272154
Catalog No.:AA00E932

5928-25-6 | Decursin

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$46.00   $32.00
- +
5mg
≥98%
in stock  
$166.00   $116.00
- +
10mg
≥98%
in stock  
$263.00   $184.00
- +
25mg
≥98%
in stock  
$600.00   $420.00
- +
50mg
98%
in stock  
$1,100.00   $770.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00E932
Chemical Name:
Decursin
CAS Number:
5928-25-6
Molecular Formula:
C19H20O5
Molecular Weight:
328.3591
MDL Number:
MFCD00272154
SMILES:
O=C(C=C(C)C)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C
Properties
Computed Properties
 
Complexity:
585  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
3  
XLogP3:
3.9  

Literature

Title: Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats.

Journal: Journal of ethnopharmacology 20121121

Title: A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.

Journal: Investigational new drugs 20121001

Title: Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20121001

Title: Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.

Journal: Journal of medicinal food 20121001

Title: A novel derivative of decursin, CSL-32, blocks migration and production of inflammatory mediators and modulates PI3K and NF-κB activities in HT1080 cells.

Journal: Cell biology international 20120701

Title: Decursin, an active compound isolated from Angelica gigas, inhibits fat accumulation, reduces adipocytokine secretion and improves glucose tolerance in mice fed a high-fat diet.

Journal: Phytotherapy research : PTR 20120501

Title: Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots.

Journal: Molecular biotechnology 20120201

Title: Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.

Journal: Planta medica 20120201

Title: Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.

Journal: Bioorganic & medicinal chemistry 20120115

Title: Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20111001

Title: Decursin from Angelicagigas Nakai induces apoptosis in RC-58T/h/SA#4 primary human prostate cancer cells via a mitochondria-related caspase pathway.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20111001

Title: Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway.

Journal: Cancer letters 20110201

Title: Protective effects of decursin and decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes.

Journal: Bioscience, biotechnology, and biochemistry 20110101

Title: Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells.

Journal: Cancer letters 20101208

Title: Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation.

Journal: Cancer letters 20101001

Title: Cloning and characterization of phenylalanine ammonia-lyase and cinnamate 4-hydroxylase and pyranocoumarin biosynthesis in Angelica gigas.

Journal: Journal of natural products 20100827

Title: Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agent.

Journal: Journal of natural products 20100528

Title: Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells.

Journal: Biological & pharmaceutical bulletin 20100101

Title: Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20090901

Title: Effects of diumancal and decursinol on 5-hydroxytryptamine level in rat brain.

Journal: Georgian medical news 20090901

Title: Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.

Journal: Journal of natural products 20090601

Title: The analgesic effect of decursinol.

Journal: Archives of pharmacal research 20090601

Title: A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma.

Journal: Biological & pharmaceutical bulletin 20090301

Title: In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.

Journal: The American journal of Chinese medicine 20090101

Title: Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.

Journal: Molecular vision 20090101

Title: Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.

Journal: PloS one 20080101

Title: Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.

Journal: Planta medica 20071101

Title: Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20071001

Title: Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.

Journal: Acta pharmacologica Sinica 20070901

Title: Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.

Journal: The Journal of pharmacy and pharmacology 20070601

Title: A novel class of pyranocoumarin anti-androgen receptor signaling compounds.

Journal: Molecular cancer therapeutics 20070301

Title: [Inhibitory effects of 11 coumarin compounds against growth of human bladder carcinoma cell line E-J in vitro].

Journal: Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20070101

Title: Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

Journal: Breast cancer research : BCR 20070101

Title: Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages.

Journal: Molecular pharmacology 20060601

Title: Molecular target of decursins in the inhibition of lipid droplet accumulation in macrophages.

Journal: Biological & pharmaceutical bulletin 20060501

Title: Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.

Journal: Cancer research 20060101

Title: Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.

Journal: Leukemia research 20051201

Title: Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.

Journal: Cancer letters 20050608

Title: A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.

Journal: Cancer research 20050201

Title: Four new neuroprotective dihydropyranocoumarins from Angelica gigas.

Journal: Journal of natural products 20050101

Title: Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20040101

Title: Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas.

Journal: Archives of pharmacal research 20030901

Title: Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.

Journal: Archives of pharmacal research 20030901

Title: Antinociceptive mechanisms of orally administered decursinol in the mouse.

Journal: Life sciences 20030613

Title: Effects of ginsenoside Rd and decursinol on the neurotoxic responses induced by kainic acid in mice.

Journal: Planta medica 20030301

Title: Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice.

Journal: Neurobiology of learning and memory 20030101

Title: Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships.

Journal: Journal of natural products 20010501

Title: Ahn KS,et al. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med. 1996;62(1):7-9.

Title: Li J, et al. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway. Phytother Res. 2018;32(12):2456-2465.

Title: Kim S, et al. Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression. Am J Cancer Res. 2019;9(9):2007-2018. Published 2019 Sep 1.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5928-25-6 Molecular Formula|5928-25-6 MDL|5928-25-6 SMILES|5928-25-6 Decursin